Johnson & Johnson stock outperforms market despite losses on the day

This post was originally published on this site

© Terrence Horan


Video: UnitedHealth beats estimates on top and bottom lines (CNBC)

UnitedHealth beats estimates on top and bottom lines
What to watch next

Shares of Johnson & Johnson slumped 0.16% to $168.10 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.75% to 4,327.16 and Dow Jones Industrial Average falling 0.86% to 34,687.85. This was the stock’s second consecutive day of losses. Johnson & Johnson closed $5.55 short of its 52-week high ($173.65), which the company reached on January 26th.

Load Error

The stock underperformed when compared to some of its competitors Friday, as Roche Holding AG Part. Cert. rose 1.98% to $388.47, Merck & Co. Inc. rose 0.15% to $78.02, and Pfizer Inc. rose 0.65% to $40.35. Trading volume (5.8 M) remained 593,986 below its 50-day average volume of 6.4 M.

Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading